Project Grant R01MH135952
- This Project Grant award from the National Institutes of Health (NIH) under the Trans-NIH Research Support program (CFDA 93.310) supports research to visualize the mechanisms at the intersection of chromatin, transcription, and epigenetics. The $1,525,500 award to Harvard Medical School aims to develop a combinatorial biochemical and structural approach called "Visual Biochemistry" that uses a fully reconstituted chromatin transcription system and time-resolved single-particle...
- This Project Grant award, valued at $481,250.00 and provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, aims to develop a synthetic biological system to manipulate subcellular RNAs and proteins in growth cones or synapses of subtype- and context-specific neurons. The goal is to enable unique forms of subcellular functional investigation in subtype- and...
- This $1,417,500 Project Grant awarded by the National Institutes of Health (NIH) under the Trans-NIH Research Support program (CFDA 93.310) funds the development of "Electrified Cryo-EM", a novel tool that can kinetically trap biological systems in their metastable, non-equilibrium states. The research aims to unravel the structural changes in neurons during an action potential across multiple length scales, from voltage-gated channel proteins to the synaptic junction. Specifically,...
- This $1,737,000 Project Grant awarded by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) supports the development of innovative single-cell genomics technologies for joint analysis of regulatory dynamics and transcriptional states. Key objectives include: Developing multiomics tools to measure rates of epigenomic changes (DNA methylation, demethylation, oxidative damage, DNA repair) and relate these to...
- This $438,342 federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, aims to study the fundamental mechanisms by which ubiquitin ligases recognize and ubiquitinate substrates within protein complexes. The research focuses on understanding the role of the anaphase-promoting complex (APC) in regulating the composition of neuronal...
- This $495,000 National Science Foundation project grant supports collaborative research at the University of Colorado Denver to explore the potential role of non-coding RNAs in encoding molecular memory. Funded under the Biological Sciences program (CFDA 47.074), the three-year award beginning May 1, 2023 will examine whether a simple form of memory known as behavioral sensitization can be stored by non-coding RNA. The principal investigators hypothesize that expression or post-transcriptional...
- This National Science Foundation project grant award of $600,000 supports research into the mechanisms underlying long-term memory storage at the University of California, Los Angeles from February 1, 2022 to January 31, 2025. The award is made under the Biological Sciences program (CFDA 47.074) to promote progress in the biological sciences. Specifically, the grant funds research investigating whether memories are stored through nuclear modifications in neurons rather than changes in...
- The National Institute of Neurological Disorders and Stroke (NINDS) awarded The Trustees of Columbia University in the City of New York, doing business as the Health Sciences Division, a $2,554,313 federal Project Grant under the 21st Century Cures Act - Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative (CFDA 93.372). The grant, which runs from Sep 1, 2023 to Aug 31, 2026, will support research to determine if targeted in vivo manipulations of local circuit control...
- Federal Project Grant Award Summary New York University School of Medicine received a $254,250 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), awarded September 25, 2025, with completion targeted for August 31, 2027. The award funds the development of genetic approaches to study the organization and function of neocortical layer 1 (L1), the...
- Federal Grant Award Summary Cold Spring Harbor Laboratory (CSHL) received a $732,475 Project Grant from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), awarded August 1, 2025, with completion targeted for April 30, 2030. The research focuses on advancing structural and functional understanding of Calcium Homeostasis Modulator (CALHM) proteins, which are large-pore...
THE IMPACT OF DNA SUPERCOILING AND TOPOISOMERASES ON NEURONAL ACTIVITY-DEPENDENT CHROMATIN ORGANIZATION - PROJECT SUMMARY EXPERIENCE-DRIVEN CHANGES TO CHROMATIN ARCHITECTURE HELP ACTIVATE GENE TRANSCRIPTION PROGRAMS THAT ALLOW ANIMALS TO LEARN AND DEVELOP ADAPTIVE BEHAVIORS. YET THE FORCES THAT REMODEL CHROMATIN IN RESPONSE TO NEURONAL ACTIVITY REMAIN OBSCURE. TORSION FROM DNA SUPERCOILING INJECTS FREE ENERGY INTO THE DNA AND HAS THE POTENTIAL TO ORGANIZE CHROMATIN, YET HOW DYNAMIC SUPERCOILING DISTRIBUTES AND ACTS WITHIN THE NEURONAL GENOME ARE POORLY UNDERSTOOD. RNA POLYMERASES (RNAPS) AND DNA TOPOISOMERASES GENERATE AND RESOLVE SUPERCOILS, RESPECTIVELY, AND THEIR CONCERTED ACTIONS AFFECT DYNAMIC SUPERCOILING DISTRIBUTION. HOWEVER, TO WHAT EXTENT SUPERCOILS PROPAGATE FROM THE SITES OF RNAP ACTIVITY, AND HOW CHROMATIN STRUCTURE AFFECTS SUPERCOIL DISTRIBUTION REMAIN UNEXPLORED. FURTHERMORE, WHILE SUPERCOILING IS A UBIQUITOUS FEATURE OF DNA TOPOLOGY, HOW TORSIONAL FREE ENERGY FROM SUPERCOILING AFFECTS CHROMATIN STRUCTURE AND GENE ACTIVITY PATTERNS IS ALSO UNKNOWN. TO ADDRESS THESE ISSUES, PSORALEN CROSSLINKING AND SEQUENCING (TMP-SEQ) WAS RECENTLY PERFORMED TO MAP THE DISTRIBUTION OF UNDERWOUND (NEGATIVELY SUPERCOILED) DNA AT HIGH RESOLUTION IN CULTURED MOUSE CORTICAL NEURONS UNDER BASAL CONDITIONS. ADDITIONALLY, NEW METHODS WERE DEVELOPED TO MAP GENOME-WIDE SITES OF CATALYTICALLY ENGAGED TOPOISOMERASES (TOP1CC-SEQ AND TOP2BCC-SEQ). THESE STUDIES REVEALED THAT SUPERCOILS TRANSMIT WIDELY (> 200 KB) FROM THE SITES OF ACTIVE RNAPS, WHILE TOPOISOMERASES ONLY ACT AT SELECTIVE LOCATIONS TO RESOLVE SUPERCOILS. THESE DATA INDICATE THAT TORSIONAL FREE ENERGY FROM SUPERCOILING COULD BE WIDELY AVAILABLE TO INFLUENCE CHROMATIN STRUCTURE. BASED ON THESE RESULTS, THIS PROJECT WILL PERFORM TMP-SEQ AT VARIOUS TIMES FOLLOWING NEURONAL STIMULATION AND ASSESS HOW ACTIVITY-DRIVEN SUPERCOILING DISTRIBUTES WITHIN THE GENOME. ADDITIONALLY, TOP1CC-SEQ AND TOP2BCC-SEQ WILL BE PERFORMED UNDER THE SAME CONDITIONS TO DETERMINE HOW TOPOISOMERASES ARE UTILIZED TO REGULATE DYNAMIC SUPERCOILING IN STIMULATED NEURONS. WHILE SUPERCOILS GENERALLY DISTRIBUTE FREELY WITHIN CHROMATIN, PRELIMINARY DATA INDICATE THAT THEY ALSO ACCRUE AT SPECIFIC NUCLEOSOME CONFIGURATIONS, PARTICULARLY AT ACTIVE PROMOTERS WITH BROAD H3K4ME3 DISTRIBUTIONS AND IN REGIONS FLANKING H3K27ME3-RICH CHROMATIN. INTRIGUINGLY, A BROADENING OF H3K4ME3 HAS BEEN OBSERVED FOLLOWING NEURONAL STIMULATION IN VIVO, SUGGESTING THAT SPECIFIC STIMULUS-DRIVEN EPIGENETIC CHANGES COULD "CONSTRAIN" DYNAMIC SUPERCOILS. THE PROPOSED RESEARCH WILL TEST THIS IDEA BY ASSESSING HOW KNOCKDOWN OF WDR5, WHICH MEDIATES H3K4 METHYLATION, AND EXPRESSION OF JMJD3, WHICH ERASES H3K27ME3, AFFECT NEURONAL ACTIVITY-DEPENDENT SUPERCOILING PATTERNS. FINALLY, TOPOISOMERASE INHIBITORS AND LOCUS-SPECIFIC MODULATORS OF DNA SUPERCOILING WILL BE USED TO PERTURB SUPERCOILING PATTERNS IN STIMULATED NEURONS, AND CHROMOSOME CONFORMATION CAPTURE (MICRO-C), ATAC-SEQ, AND NASCENT TRANSCRIPTION ANALYSIS (FASTGRO) WILL PERFORMED TO TEST THE IDEA THAT DYNAMIC SUPERCOILING HAS A CAUSAL ROLE IN NEURONAL ACTIVITY-DRIVEN CHROMATIN RECONFIGURATION. TOGETHER, THESE EFFORTS WILL PROVIDE NEW INSIGHTS INTO HOW DNA MECHANICS REGULATES NEURONAL FUNCTIONS DURING DEVELOPMENT AND DISEASE.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $547.1k | 1/21/26 | ||
| Not listed | $82.1k | 9/19/25 | ||
| Not listed | $82.1k | 9/19/25 | ||
| Not listed | $465.0k | 4/15/25 | ||
| Not listed | $465.0k | 4/15/25 |